E. Bouffet et al., Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience, BR J CANC, 79(7-8), 1999, pp. 1199-1204
Conventional therapy for intracranial germinomas is craniospinal irradiatio
n. In 1990, the Societe Francaise d'Oncologie Pediatrique initiated a study
combining chemotherapy (alternating courses of etoposide-carboplatin and e
toposide-ifosfamide for a recommended total of four courses) with 40 Gy loc
al irradiation for patients with localized germinomas. Metastatic patients
were allocated to receive low-dose craniospinal radiotherapy. Fifty-seven p
atients were enrolled between 1990 and 1996. Forty-seven had biopsy-proven
germinoma. Biopsy was not performed in ten patients (four had diagnostic tu
mour markers and in six the neurosurgeon felt biopsy was contraindicated),
Fifty-one patients had localized disease, and six leptomeningeal disseminat
ion. Seven patients had bifocal tumour. All but one patient received at lea
st four courses of chemotherapy Toxicity was mainly haematological, Patient
s with diabetus insipidus (n = 25) commonly developed electrolyte disturban
ces during chemotherapy. No patient developed tumour progression during che
motherapy, Fifty patients received local radiotherapy with a median dose of
40 Gy to the initial tumour volume. Six metastatic patients, and one patie
nt with localized disease who stopped chemotherapy due to severe toxicity,
received craniospinal radiotherapy. The median follow-up for the group was
42 months. Four patients relapsed 9, 10, 38 and 57 months after diagnosis.
Three achieved second complete remission following salvage treatment with c
hemotherapy alone or chemo-radiotherapy, The estimated 3-year survival prob
ability is 98% (CI, 86.6-99.7%) and the estimated 3-year event-free surviva
l is 96.4% (CI: 86.2-99.1%). This study shows that excellent survival rates
can be achieved by combining chemotherapy and local radiotherapy in patien
ts with non-metastatic intracranial germinomas.